217
Participants
Start Date
February 28, 2010
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
AR-12286 0.5% ophthalmic solution
q.d. PM
AR-12286 0.25% Ophthalmic solution
q.d. PM
Latanoprost ophthalmic solution
q.d. PM
Mount Sinai School Of Medicine, New York
Glaucoma Consultants of the Capital Region, Slingerlands
Rochester Ophthalmology Group, Rochester
Charlotte Eye Ear Nose and Throat, Charlotte
Coastal Research Associates, LLC, Roswell
Marvin Greenberg, MD, Tamarac
East Florida Eye Institute, Stuart
Univ Eye Surgeons, Maryville Ctr., Maryville
Taustine Eye Center, Louisville
Black Hills Regional Eye Institute, Rapid City
Comprehensive Eye Care, St Louis
Bradley Kwapiszeski, MD, Shawnee Mission
The Eye Institute, Tulsa
Texan Eye, Austin
Medical Center Ophth. Associates, San Antonio
United Medical Research Institute, Inglewood
Centre For Health Care, Poway
North Bay Eye Associates, Petaluma
Lead Sponsor
Aerie Pharmaceuticals
INDUSTRY